Mineralys Therapeutics, Common Stock Price History

Mineralys Therapeutics, Stock Price History Chart

Mineralys Therapeutics, February 26, 2025 Stock Price Synopsis

Various analyses of Mineralys Therapeutics,'s daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Mineralys Stock. It can be used to describe the percentage change in the price of Mineralys Therapeutics, from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Mineralys Stock. When benchmark price declines in a down market, there may be an uptick in Mineralys Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Mineralys Therapeutics, intraday prices and daily technical indicators to check the level of noise trading in Mineralys Stock and then apply it to test your longer-term investment strategies against Mineralys.

Mineralys Stock Price History Data

The price series of Mineralys Therapeutics, for the period between Thu, Nov 28, 2024 and Wed, Feb 26, 2025 has a statistical range of 4.37 with a coefficient of variation of 12.47. The daily prices for the period are spread out with arithmetic mean of 11.29. The median price for the last 90 days is 11.64.

Mineralys Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Mineralys is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Mineralys Therapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Mineralys Therapeutics, stock prices may prove useful in developing a viable investing in Mineralys Therapeutics,

Mineralys Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.

Predictive indicators are helping investors to find signals for Mineralys Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Mineralys Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Mineralys to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

When running Mineralys Therapeutics,'s price analysis, check to measure Mineralys Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mineralys Therapeutics, is operating at the current time. Most of Mineralys Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Mineralys Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mineralys Therapeutics,'s price. Additionally, you may evaluate how the addition of Mineralys Therapeutics, to your portfolios can decrease your overall portfolio volatility.